Tasadenoturev (DNX-2401) is an oncolytic replication-competent adenovirus with a 24 bp deletion in the E1A region of the genome, enabling the virus to replicate in cancer cells selectively and efficiently. This evidence concerns the gene DHTKD1 and cancer.